Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)
China · Delayed Price · Currency is CNY 2.580
-0.060 (-2.27%)
Apr 9, 2026, 11:29 AM CST
SHA:600252 Revenue
In the year 2025, Guangxi Wuzhou Zhongheng Group had annual revenue of 1.75B CNY, down -23.00%. Guangxi Wuzhou Zhongheng Group had revenue of -199.54M in the quarter ending December 31, 2025.
Revenue
1.75B
Revenue Growth
-16.92%
P/S Ratio
4.81
Revenue / Employee
588.55K
Employees
2,971
Market Cap
8.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.75B | -522.24M | -23.00% |
| Dec 31, 2024 | 2.27B | -825.72M | -26.67% |
| Dec 31, 2023 | 3.10B | 382.77M | 14.10% |
| Dec 31, 2022 | 2.71B | -448.07M | -14.17% |
| Dec 31, 2021 | 3.16B | -514.55M | -14.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KPC Pharmaceuticals,Inc. | 6.58B |
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Tianjin Ringpu Bio-Technology | 3.40B |
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Jiuzhitang | 2.23B |
| Guilin Sanjin Pharmaceutical | 2.08B |
| PharmaBlock Sciences (Nanjing) | 1.98B |